Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA728241 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Smoking and Obesity Related Molecular Alterations in Clear Cell Renal Cell Carcinoma
2025-01-24 | E-GEOD-46699 | ExpressionAtlas
Project description:Gene array analysis of clear cell renal cell carcinoma tissue versus matched normal kidney tissue
2025-01-24 | E-GEOD-53757 | ExpressionAtlas
Project description:Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues
2025-01-16 | E-TABM-282 | ExpressionAtlas
Project description:Systematic somatic mutation screening in human clear cell renal cell carcinoma reveals inactivation of chromatin modification genes
2009-10-01 | E-TABM-770 | biostudies-arrayexpress
Project description:The ubiquitin proteasome system governs a wide spectrum of cellular events and offers therapeutic opportunities for pharmacological intervention in cancer treatment. Renal clear cell carcinoma represents the predominant histological subtype and accounts for the majority of cancer death related to kidney malignancies. Through a systematic survey in the association of human ubiquitin-specific proteases with patient prognosis of renal clear cell carcinoma and subsequent phenotypic validation, we uncovered the tumor-promoting role of USP35. Biochemical characterizations confirmed the stabilizing effects of USP35 towards multiple members of the IAP family in an enzymatic activity-dependent manner. USP35 silencing led to reduced expression levels of IAP proteins, which were accompanied with increased cellular apoptosis. Further transcriptomic analysis revealed that USP35 knockdown altered expression levels of NRF2 downstream transcripts, which were conferred by compromised NRF2 abundance. USP35 functions to maintain NRF2 levels by catalyzing its deubiquitylation and thus antagonizing degradation. NRF2 reduction imposed by USP35 silencing rendered renal clear cell carcinoma cells increased sensitivity to ferroptosis induction. Finally, induced USP35 knockdown markedly attenuated xenograft formation of renal clear cell carcinoma in nude mice. Hence, our findings identify a number of USP35 substrates and reveal the protecting role of USP35 against both apoptosis and ferroptosis in renal clear cell carcinoma.
2023-06-17 | GSE216154 | GEO
Project description:Homo sapiens KCCAT198, renal clear cell carcinoma-associated transcript 198 [Source:NCBI gene (formerly Entrezgene);Acc:105369954], is expressed in 24 baseline experiment(s);
| ENSG00000257642 | ExpressionAtlas
Project description:Homo sapiens KCCAT198, renal clear cell carcinoma-associated transcript 198 [Source:NCBI gene (formerly Entrezgene);Acc:105369954], is differentially expressed in 6 experiment(s);
| ENSG00000257642 | ExpressionAtlas
Project description:RNA-seq upon PAX8 knockdown in Renal Cell Carcinoma cell lines
2025-01-23 | E-MTAB-7808 | ExpressionAtlas
Project description:Treatment of renal cell carcinoma cell line A-498 with zebularine
2025-01-24 | E-GEOD-51627 | ExpressionAtlas
Project description:This SuperSeries is composed of the following subset Series: GSE17816: Somatic Mutation Screen of Clear Cell RCC I GSE17818: Somatic Mutation Screen of Clear Cell RCC II Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/.
2010-05-16 | E-GEOD-17895 | biostudies-arrayexpress